Cargando…
CYP24A1 variant modifies the association between use of oestrogen plus progestogen therapy and colorectal cancer risk
BACKGROUND: Menopausal hormone therapy (MHT) use has been consistently associated with a decreased risk of colorectal cancer (CRC) in women. Our aim was to use a genome-wide gene–environment interaction analysis to identify genetic modifiers of CRC risk associated with use of MHT. METHODS: We includ...
Ejemplares similares
-
Genome-Wide Diet-Gene Interaction Analyses for Risk of Colorectal Cancer
por: Figueiredo, Jane C., et al.
Publicado: (2014) -
Gender Discrepancies in SARS-CoV-2 Pandemic Related Beliefs, Attitudes, and Practices
por: Pflugeisen, Bethann Mangel, et al.
Publicado: (2021) -
Progesterone and progestogens
por: Lipinski, Joanne
Publicado: (2022) -
Estrogens and Progestogens in Triple Negative Breast Cancer: Do They Harm?
por: van Barele, Mark, et al.
Publicado: (2021) -
Socioeconomic and Racial Inequities in Breast Cancer Screening During the COVID-19 Pandemic in Washington State
por: Amram, Ofer, et al.
Publicado: (2021)